Consensus iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
111.3 ^USD	-4.43%		-0.76%	+3.95%

Mar. 08	IRhythm Technologies Closes $661 Million Notes Offering	MT
Mar. 05	Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	MT

Evolution of the average Target Price on iRhythm Technologies, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1dbdb598ad84ef9cf1cb0190775b4f7f.3xuMpV7MxKoUVEoX4-CCSotp9mQni1rT2c4qPhrsxrM.uzbt_WmCqOBxGAJZobC7HMkuhRxyzhGKv71ldUqq_4OcYvTiM_6g_WQfJQ~7b6feee3529e4f78699eba3d86f9f529

Analyst Recommendations on iRhythm Technologies, Inc.

Needham Adjusts iRhythm Technologies' Price Target to $137 From $136, Keeps Buy Rating	Feb. 23	MT
Needham Raises iRhythm Technologies' Price Target to $136 From $108, Keeps Buy Rating	Jan. 08	MT
Truist Securities Adjusts iRhythm Technologies Price Target to $115 From $100, Maintains Buy Rating	Dec. 12	MT
Citigroup Upgrades iRhythm Technologies to Buy From Neutral, Raises Price Target to $110 From $85	Dec. 11	MT
Morgan Stanley Adjusts Price Target on iRhythm Technologies to $135 From $149, Maintains Overweight Rating	23-10-11	MT
Canaccord Genuity Adjusts Price Target on iRhythm Technologies to $116 From $136, Maintains Buy Rating	23-08-28	MT
Truist Adjusts iRhythm Technologies' Price Target to $138 From $155, Keeps Buy Rating	23-08-07	MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $165 From $125, Maintains Outperform Rating	23-08-04	MT
Needham Adjusts Price Target on iRhythm Technologies to $130 From $151, Keeps Buy Rating	23-08-04	MT
BTIG Adjusts iRhythm Technologies' Price Target to $140 From $165, Keeps Buy Rating	23-06-08	MT
Citigroup Adjusts Price Target on iRhythm Technologies to $115 From $135, Maintains Neutral Rating	23-06-07	MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $125 From $166, Maintains Outperform Rating	23-06-07	MT
Truist Securities Adjusts Price Target on iRhythm Technologies to $155 From $154, Maintains Buy Rating	23-05-05	MT
Citigroup Adjusts Price Target on iRhythm Technologies to $135 From $130, Maintains Neutral Rating	23-05-05	MT
Needham Raises Price Target on iRhythm Technologies to $151 From $133, Maintains Buy Rating	23-05-05	MT
BTIG Adjusts iRhythm Technologies' Price Target to $170 From $168, Keeps Buy Rating	23-04-17	MT
Truist Securities Adjusts Price Target on iRhythm Technologies to $154 From $137, Keeps Buy Rating	23-04-17	MT
Citigroup Adjusts iRhythm Technologies Price Target to $130 From $110, Maintains Neutral Rating	23-04-03	MT
Canaccord Genuity Adjusts iRhythm Technologies' Price Target to $143 From $135, Keeps Buy Rating	23-02-24	MT
Morgan Stanley Adjusts Price Target on iRhythm Technologies to $130 From $128, Maintains Overweight Rating	23-02-24	MT
Needham Adjusts Price Target on iRhythm Technologies to $133 From $140, Maintains Buy Rating	23-02-24	MT
Wells Fargo Initiates iRhythm Technologies at Overweight Rating With $150 Price Target	23-02-07	MT
Morgan Stanley Adjusts Price Target on iRhythm Technologies to $128 From $165, Maintains Overweight Rating	23-01-06	MT
Truist Securities Adjusts Price Target on iRhythm Technologies to $153 From $167, Maintains Buy Rating	22-12-20	MT
Citigroup Cuts Price Target on iRhythm Technologies to $110 From $144, Keeps Neutral Rating	22-12-12	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

111.3 USD

Average target price

138.5 USD

Spread / Average Target

+24.47%

High Price Target

165 USD

Spread / Highest target

+48.29%

Low Price Target

132 USD

Spread / Lowest Target

+18.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering iRhythm Technologies, Inc.

Needham & Co.
Truist Securities
Citigroup
Morgan Stanley
Canaccord Genuity
Oppenheimer
BTIG
Wells Fargo Securities
JPMorgan Chase
Wolfe Research
J.P. Morgan Chase
Baird
Colliers Securities

Ratings for iRhythm Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar